Researcher
Anne Uyttebroeck
- Disciplines:Morphological sciences, Oncology
Affiliations
- Pediatric Oncology (Division)
Member
From24 Jul 2018 → Today - Department of Oncology (Department)
Member
From1 Jan 2018 → 23 Jul 2018 - Woman and Child (Division)
Member
From1 Apr 2013 → 31 Dec 2017
Projects
1 - 8 of 8
- The neuro-oncological connectome: towards hub-driven analyses and neurocognition-sparing treatments for brain tumorsFrom1 Oct 2021 → 31 Jul 2022Funding: FWO junior postdoctoral fellowship
- Dynamic monitoring and risk assessment of chronic fatigue in survivors of childhood cancerFrom1 Apr 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivorsFrom1 Mar 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Dynamic monitoring and risk assessment of chronic fatigue in survivors of childhood cancer.From1 Jan 2021 → 31 Dec 2022Funding: FWO Humanitarian research project Stand up against Cancer
- PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversFrom1 Jan 2019 → 31 Dec 2023Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Therapeutic delivery of exosome-microRNAs in pediatric rhabdomyosarcomaFrom5 Sep 2016 → 29 Nov 2021Funding: FWO Strategic Basic Research Grant
- Single cell molecular analysis of acute lymphoblastic leukemiaFrom1 Aug 2014 → 30 Sep 2018Funding: FWO fellowships
- From individual cancer genes to integrated cancer pathways in childhood cancer.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
Publications
131 - 140 of 193
- IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951(2015)
Authors: Anne Uyttebroeck
Pages: 2154 - 61 - Executive Dysfunction 25 Years after Treatment with Cranial Radiotherapy for Pediatric Lymphoid Malignancies(2015)
Authors: Anne Uyttebroeck
Pages: 657 - 69 - Risk-adapted therapy for patients with relapsed or refractory ALCL - final report of the prospective ALCL-relapse trial of the EICNHL(2015)
Authors: Anne Uyttebroeck
Pages: 45 - 45 - Second and subsequent relapses of ALCL: EICNHL experience(2015)
Authors: Noemie Lavoine, Marie-Cecile Le Deley, Wilhelm Woessmann, Marta Pillon, Denise Williams, Keizo Horibe, Grazyna Wrobel, Andishe Attarbaschi, Auke Bezhuisen, Anne Uyttebroeck, et al.
Pages: 55 - 55 - Executive Dysfunction 25 Years after Treatment with Cranial Radiotherapy for Pediatric Lymphoid Malignancies(2015)
Authors: Ilse Schuitema, Leo de Sonneville, Gertjan Kaspers, Helena van der Pal, Anne Uyttebroeck, Cor van den Bos, Anjo Veerman
Pages: 657 - 69 - CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol(2015)
Authors: Anne Uyttebroeck
Pages: 1311 - 9 - Hedgehog pathway mutations in T-cell acute lymphoblastic leukemia(2015)
Authors: Ellen Geerdens, Barbara Cauwelier, Thomas Tousseyn, Anne Uyttebroeck, Johan Maertens, Gregor Verhoef, Peter Vandenberghe, Jan Cools
Pages: E102 - E105 - Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study(2015)
Authors: Peter Vandenberghe, Thomas Tousseyn, Daan Dierickx, Magali Verheecke, Anne Uyttebroeck, Oliver Bechter, Michel Delforge, Vincent Vandecaveye, Nathalie Brison, Gregor Verhoef, et al.
Pages: E55 - E65 - Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial(2014)
Authors: Anne Uyttebroeck
Pages: 1220 - 1227 - qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma(2014)
Authors: Anne Uyttebroeck
Pages: 1301 - 8